"Welcome to the psychedelic '20s!" Rick Doblin, founder of the Multidisciplinary Association for Psychedelic Studies, or MAPS, proclaimed in his keynote speech to open the Psychedelic Science 2023 conference. At the event organized by MAPS in Denver this June, a reported 13,000 people gathered to talk about what seemed like every possible topic related to the productive use of these substances.
Founded in the late 1980s, MAPS has spent decades working to get approval from the Food and Drug Administration (FDA) for MDMA-assisted therapy for PTSD and related conditions.
